Private Equity's Inversion Excursion: Pepper Hamilton Talks Tax With the Deal
To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more
In the past week, the FDA authorized Pfizer’s and Merck’s oral antivirals for the treatment of COVID-19. The Biden-Harris Administration released the Trucking Action Plan. The CDC endorsed ACIP recommendation of preference...more
In Washington: The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) on Friday lifted the recommended pause on the use of Johnson & Johnson’s coronavirus vaccine, saying the benefits...more
The FDA could approve two COVID-19 vaccines within a matter of days. However, drug makers have tried to keep expectations in check about how much vaccine they can deliver immediately and over the next few months as they...more
In Washington - FEMA administrator Peter Gaynor cautiously told the House Homeland Security Committee yesterday that personal protective equipment (PPE) distribution in the U.S. is “healthy” but admitted that the agency...more